Source: Annual Congress 2011 - Recent developments in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Balode, G. Strazda, N. Jurka, U. Kopeika, A. Kislina, M. Beinare, M. Bukovskis, I. Taivans (Riga, Latvia). LSC 2011 Abstract: The role of lipoxin A4 in the chronic obstructive pulmonary disease. Eur Respir J 2011; 38: Suppl. 55, 414

Member's Comments

No comment yet.

Related content which might interest you: Chronic obstructive pulmonary disease is characterized with suppressed lipoxin A4 and increased lipoxin receptor expression in lungs Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012 Investigation of the role of miRNAs as a biomarker in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012 Survivin in patients with chronic obstructive pulmonary disease Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Chronic obstructive pulmonary disease (COPD) – patient‘s perspective Source: Eur Respir J 2007; 30: Suppl. 51, 168s Year: 2007 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Pentraxin 3 as a novel biomarker of inflammation in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Chronic obstructive pulmonary disease: the patient perspective Source: Eur Respir J 2001; 18: Suppl. 33, 401s Year: 2001 Interleukin-18 production and pulmonary function in COPD Source: Eur Respir J 2008; 31: 287-297 Year: 2008 Platelets activation during chronic obstructive pulmonary disease (COPD) exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 89s Year: 2002 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 LSC Abstract – microRNA profiling reveals a role for microRNA-218-5p in the pathogenesis of chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021 Biomarkers in the management of COPD Source: Eur Respir Rev 2009; 18: 96-104 Year: 2009 Hedgehog-interacting protein is a COPD susceptibility gene: the Rotterdam Study Source: Eur Respir J 2010; 36: 89-95 Year: 2010 Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 Adenosine-receptor subtypes: their relevance to adenosine-mediated responses in asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 488-496 Year: 2002 Local and systemic inflammation in chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Granulocytic myeloid-derived-supressor cells (GrMDSCs) in chronic obstructive pulmonary disease (COPD) patients Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Dynamics of sputum antimicrobial peptide levels in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 Role of antibiotics in exacerbations of chronic obstructive pulmonary disease: a Cochrane review Source: Annual Congress 2006 - COPD and inflammation Year: 2006